Kiwa Bio-tech Products Group Corp (KWBT) financial statements (2020 and earlier)

Company profile

Business Address 3200 GUASTI ROAD,
ONTARIO, CA 91761
State of Incorp. NV
Fiscal Year End December 31
SIC 287 - Agricultural Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 81,084131
Cash and cash equivalents 81,084131
Receivables 6,763481,123 
Inventory, net of allowances, customer advances and progress billings 1,6432,746  
Inventory 1,6432,746  
Prepaid expense 2,2602,4741,418 
Deferred costs 4,93017  
Other undisclosed current assets 16,08712,7051,91947
Total current assets: 31,69019,0734,47348
Noncurrent Assets
Property, plant and equipment 9391553
Long-term investments and receivables 7277681,522 
Long-term investments 727768  
Due from related parties   1,522 
Deposits noncurrent assets 17335 
Total noncurrent assets: 8219311,6123
TOTAL ASSETS: 32,51120,0056,08551
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 7,6044,9914,1683,341
Accounts payable 1,6111,8011,073300
Employee-related liabilities 1,0252911,1551,633
Taxes payable 2,9471,143415478
Interest and dividends payable 2,0211,7561,525930
Debt 360360360360
Derivative instruments and hedges, liabilities 7248  
Due to related parties 571 2614,310
Disposal group, including discontinued operation   4,465 
Deferred revenue and credits29  
Contract with customer, liability6,751
Other liabilities 2,9402,109925524
Other undisclosed current liabilities 1,5521,137150843
Total current liabilities: 19,7858,87410,3299,378
Noncurrent Liabilities
Long-term debt and lease obligation  460 1,773
Long-term debt, excluding current maturities  460 1,773
Total noncurrent liabilities:  460 1,773
Total liabilities: 19,7859,33410,32911,151
Stockholders' equity
Stockholders' equity attributable to parent, including: 12,72710,671(4,244)(11,100)
Preferred stock   11
Common stock 171592
Common stock, share subscribed but unissued, subscriptions receivable (1,023)458127 
Additional paid in capital 27,04724,45515,2359,491
Accumulated other comprehensive income (loss) (558)324(54)(269)
Accumulated deficit (14,804)(14,583)(19,561)(20,325)
Other undisclosed stockholders' equity attributable to parent 2,0471  
Total stockholders' equity: 12,72710,671(4,244)(11,100)
TOTAL LIABILITIES AND EQUITY: 32,51120,0056,08551

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 30,65017,2709,621 
Cost of revenue
(Cost of Goods and Services Sold)
 (22,392)(11,846)(7,200) 
Gross profit: 8,2585,4242,421 
Operating expenses (5,669)(3,628)(1,548)(493)
Operating income (loss): 2,5891,796873(493)
Nonoperating income (expense) (339)121594185
Foreign currency transaction gain (loss), before tax 55(59)  
Interest and debt expense (635)(524)(90)113
Other undisclosed income from continuing operations before equity method investments, income taxes 635524  
Income (loss) from continuing operations before equity method investments, income taxes: 2,2501,9171,376(195)
Other undisclosed income (loss) from continuing operations before income taxes   90(482)
Income (loss) from continuing operations before income taxes: 2,2501,9171,466(677)
Income tax expense (benefit) 1,9061,103(425) 
Other undisclosed loss from continuing operations (3,812)(2,207)  
Income (loss) from continuing operations: 3448141,042(677)
Income (loss) from discontinued operations  4,495(150) 
Net income (loss) available to common stockholders, diluted: 3445,309891(677)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss): 3445,309891(677)
Other comprehensive income (loss) (882)378215424
Comprehensive income (loss), net of tax, attributable to parent: (538)5,6871,106(253)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: